Ausgabe 1/2005
Inhalt (13 Artikel)
Concepts of patients with alopecia areata about their disease
Alireza Firooz, Mehdi Rashighi Firoozabadi, Behnaz Ghazisaidi, Yahya Dowlati
Acne and smoking: is there a relationship?
Alireza Firooz, Reza Sarhangnejad, Seyyed Massoud Davoudi, Mansour Nassiri-Kashani
The relationship between video display terminals (VDTs) usage and dermatologic manifestations : a cross sectional study
Omid Aminian, Parvin Mansoori, Akbar Sharifian, Ehsan Rafeemanesh, Maria Mazaheri, Mohammadreza Iraniha
Introducing the National Library for Health Skin Conditions Specialist Library
Douglas Grindlay, Maged N Kamel Boulos, Hywel C Williams
Erythroderma: A clinical study of 97 cases
Maryam Akhyani, Zahra S Ghodsi, Siavash Toosi, Hossein Dabbaghian
Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population
Shahin Aghaei
Pruritus in hemodialysis patients
Maryam Akhyani, Mohammad-Reza Ganji, Nasrin Samadi, Behnaz Khamesan, Maryam Daneshpazhooh
Computer-aided dermoscopy for diagnosis of melanoma
Masoomeh Barzegari, Haiedeh Ghaninezhad, Parisa Mansoori, Arash Taheri, Zahra S Naraghi, Masood Asgari
Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series
Michelle A Lowes, James A Turton, James G Krueger, Ross StC Barnetson
Collecting a set of psoriasis family material through a patient organisation; clinical characterisation and presence of additional disorders
Annica Inerot, Charlotta Enerbäck, Fredrik Enlund, Tommy Martinsson, Lena Samuelsson, Jan Wahlström, Gunnar Swanbeck
Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients
Hassan Seyrafi, Maryam Akhiani, Hamed Abbasi, Sahar Mirpour, Ali Gholamrezanezhad
A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis
Joseph Mathew, May Y Leong, Nick Morley, Alastair D Burt
Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139]
Jean-Paul Ortonne, Neil Shear, Stephen Shumack, Eric Henninger